---
title: "Subdued Growth No Barrier To Piper Sandler Companies' (NYSE:PIPR) Price"
description: "Piper Sandler Companies (NYSE:PIPR) has a high P/E ratio of 30.7x, suggesting it may be overvalued compared to the market average. Despite a strong earnings growth of 50% last year, the company has se"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/258241188.md"
published_at: "2025-09-21T15:25:35.000Z"
---

# Subdued Growth No Barrier To Piper Sandler Companies' (NYSE:PIPR) Price

> Piper Sandler Companies (NYSE:PIPR) has a high P/E ratio of 30.7x, suggesting it may be overvalued compared to the market average. Despite a strong earnings growth of 50% last year, the company has seen a 22% decline in EPS over the past three years. This raises concerns about sustainability, as the market expects a 15% growth. Investors may be overly optimistic, risking a decline in share price if earnings do not improve. Additionally, there are three warning signs to consider regarding the company's future performance.

**Piper Sandler Companies'** (NYSE:PIPR) price-to-earnings (or "P/E") ratio of 30.7x might make it look like a strong sell right now compared to the market in the United States, where around half of the companies have P/E ratios below 19x and even P/E's below 11x are quite common. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so lofty.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

With earnings growth that's exceedingly strong of late, Piper Sandler Companies has been doing very well. It seems that many are expecting the strong earnings performance to beat most other companies over the coming period, which has increased investors’ willingness to pay up for the stock. You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.

Check out our latest analysis for Piper Sandler Companies

We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our **free** report on Piper Sandler Companies' earnings, revenue and cash flow.

## What Are Growth Metrics Telling Us About The High P/E?

The only time you'd be truly comfortable seeing a P/E as steep as Piper Sandler Companies' is when the company's growth is on track to outshine the market decidedly.

If we review the last year of earnings growth, the company posted a terrific increase of 50%. However, this wasn't enough as the latest three year period has seen a very unpleasant 22% drop in EPS in aggregate. So unfortunately, we have to acknowledge that the company has not done a great job of growing earnings over that time.

Weighing that medium-term earnings trajectory against the broader market's one-year forecast for expansion of 15% shows it's an unpleasant look.

With this information, we find it concerning that Piper Sandler Companies is trading at a P/E higher than the market. Apparently many investors in the company are way more bullish than recent times would indicate and aren't willing to let go of their stock at any price. Only the boldest would assume these prices are sustainable as a continuation of recent earnings trends is likely to weigh heavily on the share price eventually.

## The Key Takeaway

While the price-to-earnings ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of earnings expectations.

We've established that Piper Sandler Companies currently trades on a much higher than expected P/E since its recent earnings have been in decline over the medium-term. When we see earnings heading backwards and underperforming the market forecasts, we suspect the share price is at risk of declining, sending the high P/E lower. If recent medium-term earnings trends continue, it will place shareholders' investments at significant risk and potential investors in danger of paying an excessive premium.

And what about other risks? Every company has them, and we've spotted **3 warning signs for Piper Sandler Companies** (of which 1 is significant!) you should know about.

If these **risks are making you reconsider your opinion on Piper Sandler Companies**, explore our interactive list of high quality stocks to get an idea of what else is out there.

### Related Stocks

- [PIPR.US - Piper Sandler Cos](https://longbridge.com/en/quote/PIPR.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Piper Sandler 超出第四季度收入预期，并宣布分红 | Piper Sandler 报告第四季度收入增长 39%，超出分析师预期，净收入同比增长 65%。公司宣布派发 5 美元的特别股息，并宣布进行 4 股换 1 股的股票拆分。顾问服务推动了创纪录的收入，而企业投资银行和机构经纪业务也做出了积极 | [Link](https://longbridge.com/en/news/275122875.md) |
| Piper Sandler 的收益报告可能会带来哪些期待 | Piper Sandler (NYSE:PIPR) 将于 2026 年 2 月 6 日发布季度财报，分析师预计每股收益（EPS）为 4.75 美元。该公司此前超出 EPS 预期 0.67 美元，尽管公告后股价下跌了 0.0%。目前股价为 3 | [Link](https://longbridge.com/en/news/274995116.md) |
| 人工智能的红利能否扩散至少数科技巨头之外？ | 市场集中度处于历史高位，标普 500 指数市值接近 GDP 的 200%。专家讨论美联储降息的短期支撑与长期经济状况的影响，以及人工智能的红利是否能扩散至更多企业。尽管 2025 年市场涨幅显著，主要集中在少数股票上，但高估值指标如市盈率（ | [Link](https://longbridge.com/en/news/275775925.md) |
| AI 恐慌压垮了软件——但市场真的错了吗？ | AI 颠覆软件的恐慌导致板块遭无差别抛售，但机构指出软件正被 AI 增强而非取代。市场已过度反应：软件市盈率从 51 倍骤降至 27 倍，低于汽车、半导体等板块。数据印证分化：AI 采用者盈利修正幅度比受干扰者高出 102%。积极整合 AI | [Link](https://longbridge.com/en/news/275909538.md) |
| 腾讯被错杀了？ | 伯恩斯坦认为，腾讯股价下跌，主要受 AI 模型开发进度落后和游戏行业 AI 颠覆担忧的双重打击。目前腾讯以 14-15 倍 2027 年预期市盈率交易，接近 2022-2023 年行业面临游戏审批停滞和疫情封控时的低谷水平。尽管腾讯在聊天机 | [Link](https://longbridge.com/en/news/275903716.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.